0.8855
-0.0648 (-6.82%)
-0.0648 (-6.82%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Heat Biologics Inc | HTBX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.0648 | -6.82% | 0.8855 | 0.8531 | 1.16 | 1.16 | 0.9503 | 10:58:42 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.8838 | 0.8862 | 0.0024 | 0.27% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 27,731 | 23,222,618 | $ 1.05 | $ 24,434,216 | 7,082,449 | 0.1811 - 1.25 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 10:58:42 | 100 | $ 0.8855 | USD |
Heat Biologics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 89.75M | 84.67M | 80.91M | $ 3.05M | $ - | -0.59 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 2.00 | 4.50% |
Heat Biologics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HTBX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.73 | 1.16 | 0.70 | 0.8592961 | 15,514,547 | 0.1555 | 21.3% |
| 1 Month | 0.583 | 1.16 | 0.517 | 0.7161217 | 8,655,959 | 0.3025 | 51.89% |
| 3 Months | 0.50 | 1.25 | 0.435 | 0.7428113 | 12,926,307 | 0.3855 | 77.1% |
| 6 Months | 0.48 | 1.25 | 0.1811 | 0.6953185 | 8,384,169 | 0.4055 | 84.48% |
| 1 Year | 0.738 | 1.25 | 0.1811 | 0.6923478 | 4,302,880 | 0.1475 | 19.99% |
| 3 Years | 7.10 | 7.89 | 0.1811 | 1.16 | 1,874,548 | -6.21 | -87.53% |
| 5 Years | 62.60 | 75.90 | 0.1811 | 4.11 | 1,467,334 | -61.71 | -98.59% |
Heat Biologics Description
| Heat Biologics Inc is a US-based immuno-oncology company. It is engaged in developing therapies that activate a patient's immune system against cancer utilizing an engineered form of gp96. The group's T cell-stimulating therapeutic vaccine platform technologies, Immune Pan-Antigen Cytotoxic Therapy (ImPACT) and Combination Pan-Antigen Cytotoxic Therapy (ComPACT), form the basis of its product candidates. Through ImPACT, it developed product candidates consisting of live, genetically-modified, irradiated human cancer cells that secrete tumor-associated antigens together with an immune response stimulator called gp96. Through ComPACT, the firm engineered product candidates that incorporate ligand fusion proteins targeting co-stimulatory receptors into the gp96-Ig expression vector. |
